Related references
Note: Only part of the references are listed.Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [C-11]PBR28 PET Brain Imaging Study
Peter S. Bloomfield et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Sympathetic Release of Splenic Monocytes Promotes Recurring Anxiety Following Repeated Social Defeat
Daniel B. McKim et al.
BIOLOGICAL PSYCHIATRY (2016)
Innate and adaptive immunity in the development of depression: An update on current knowledge and technological advances
Rita Haapakoski et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders
Rebecca J. Henry et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Clinical studies of neuroinflammatory mechanisms in schizophrenia
Crystal C. Watkins et al.
SCHIZOPHRENIA RESEARCH (2016)
Molecular Mechanisms and Timing of Cortical Immune Activation in Schizophrenia
David W. Volk et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Activation of murine microglial N9 cells is attenuated through cannabinoid receptor CB2 signaling
Lei Ma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Imipramine attenuates neuroinflammatory signaling and reverses stress-induced social avoidance
Karol Ramirez et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Endocannabinoids drive the acquisition of an alternative phenotype in microglia
M. Mecha et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
The Effects of Psychological Stress on Microglial Cells in the Brain
Ti-Fei Yuan et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2015)
Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats
Erica Zamberletti et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Early post-stressor intervention with minocycline, a second-generation tetracycline, attenuates post-traumatic stress response in an animal model of PTSD
Yechiel Levkovitz et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Effects of Pubertal Cannabinoid Administration on Attentional Set-Shifting and Dopaminergic Hyper-Responsivity in a Developmental Disruption Model of Schizophrenia
Felipe V. Gomes et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Cannabidiol Attenuates Sensorimotor Gating Disruption and Molecular Changes Induced by Chronic Antagonism of NMDA receptors in Mice
Felipe V. Gomes et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Microglia Disrupt Mesolimbic Reward Circuitry in Chronic Pain
Anna M. W. Taylor et al.
JOURNAL OF NEUROSCIENCE (2015)
The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission
Silvia Rossi et al.
NEUROPHARMACOLOGY (2015)
Microglia in neuronal plasticity: Influence of stress
Jean-Christophe Delpech et al.
NEUROPHARMACOLOGY (2015)
PERIPHERAL AND CENTRAL EFFECTS OF REPEATED SOCIAL DEFEAT STRESS: MONOCYTE TRAFFICKING, MICROGLIAL ACTIVATION, AND ANXIETY
B. F. Reader et al.
NEUROSCIENCE (2015)
Fluoxetine prevents the development of depressive-like behavior in a mouse model of cancer related fatigue
Diana M. Norden et al.
PHYSIOLOGY & BEHAVIOR (2015)
Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol
Felipe V. Gomes et al.
SCHIZOPHRENIA RESEARCH (2015)
Effects of minocycline add-on treatment on brain morphometry and cerebral perfusion in recent-onset schizophrenia
Cristiano Chaves et al.
SCHIZOPHRENIA RESEARCH (2015)
Depression as a Microglial Disease
Raz Yirmiya et al.
TRENDS IN NEUROSCIENCES (2015)
Monocyte trafficking to the brain with stress and inflammation: a novel axis of immune-to-brain communication that influences mood and behavior
Eric S. Wohleb et al.
FRONTIERS IN NEUROSCIENCE (2015)
CB1 and CB2 Cannabinoid Receptor Antagonists Prevent Minocycline-Induced Neuroprotection Following Traumatic Brain Injury in Mice
Ana Belen Lopez-Rodriguez et al.
CEREBRAL CORTEX (2015)
Re-establishment of Anxiety in Stress-Sensitized Mice Is Caused by Monocyte Trafficking from the Spleen to the Brain
Eric S. Wohleb et al.
BIOLOGICAL PSYCHIATRY (2014)
Proinflammatory milieu in combat-related PTSD is independent of depression and early life stress
Daniel Lindqvist et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
Neuroinflammation in bipolar disorder - A [11C]-(R)-PK11195 positron emission tomography study
Bartholomeus C. M. (Benno) Haarman et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
Minocycline rescues decrease in neurogenesis, increase in microglia cytokines and deficits in sensorimotor gating in an animal model of schizophrenia
Daniele Mattei et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides
Susana G. Torres-Platas et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
Sex-dependent long-term effects of adolescent exposure to THC and/or MDMA on neuroinflammation and serotoninergic and cannabinoid systems in rats
Ana Belen Lopez-Rodriguez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Regulatory role of the cannabinoid CB2 receptor in stress- induced neuroinflammation in mice
S. Zoppi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Evidence for an Immune Role on Cognition in Schizophrenia: A Systematic Review
Rafael Ribeiro-Santos et al.
CURRENT NEUROPHARMACOLOGY (2014)
Lithium ameliorates lipopolysaccharide-induced microglial activation via inhibition of toll-like receptor 4 expression by activating the PI3K/Akt/FoxO1 pathway
Hongquan Dong et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Microglia of Prefrontal White Matter in Suicide
Tatiana P. Schnieder et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2014)
Ultralow Doses of Cannabinoid Drugs Protect the Mouse Brain From Inflammation-Induced Cognitive Damage
Miriam Fishbein-Kaminietsky et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2014)
Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis
T. Kreisel et al.
MOLECULAR PSYCHIATRY (2014)
CB1 cannabinoid receptor stimulation during adolescence impairs the maturation of GABA function in the adult rat prefrontal cortex
D. K. Cass et al.
MOLECULAR PSYCHIATRY (2014)
Biological insights from 108 schizophrenia-associated genetic loci
Stephan Ripke et al.
NATURE (2014)
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Marco Prinz et al.
NATURE REVIEWS NEUROSCIENCE (2014)
Programming of neural cells by (endo) cannabinoids: from physiological rules to emerging therapies
Mauro Maccarrone et al.
NATURE REVIEWS NEUROSCIENCE (2014)
Immunology of Major Depression
Norbert Mueller
NEUROIMMUNOMODULATION (2014)
Further evidence for the role of interferon-gamma on anxiety- and depressive-like behaviors: Involvement of hippocampal neurogenesis and NGF production
Alline C. Campos et al.
NEUROSCIENCE LETTERS (2014)
CB2 receptor agonism reverses MK-801-induced disruptions of prepulse inhibition in mice
Ramy Khella et al.
PSYCHOPHARMACOLOGY (2014)
Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update
Iris E. Sommer et al.
SCHIZOPHRENIA BULLETIN (2014)
Stress regulates endocannabinoid-CB1 receptor signaling
Cecilia J. Hillard
SEMINARS IN IMMUNOLOGY (2014)
Young adult sequelae of adolescent cannabis use: an integrative analysis
Edmund Silins et al.
LANCET PSYCHIATRY (2014)
Potent and multiple regulatory actions of microglial glucocorticoid receptors during CNS inflammation
M. A. Carrillo-de Sauvage et al.
CELL DEATH AND DIFFERENTIATION (2013)
Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia
S. G. Fillman et al.
MOLECULAR PSYCHIATRY (2013)
Peripheral Endocannabinoid System Dysregulation in First-Episode Psychosis
Miquel Bioque et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Cannabinoids and glucocorticoids modulate emotional memory after stress
Irit Akirav
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
Social stress up-regulates inflammatory gene expression in the leukocyte transcriptome via β-adrenergic induction of myelopoiesis
Nicole D. Powell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Inflammation and Schizophrenia
Brian Kirkpatrick et al.
SCHIZOPHRENIA BULLETIN (2013)
Quantification of endocannabinoids in postmortem brain of schizophrenic subjects
Carolina Muguruza et al.
SCHIZOPHRENIA RESEARCH (2013)
Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: Reversal by clozapine
Bruna Mara Machado Ribeiro et al.
SCHIZOPHRENIA RESEARCH (2013)
Association study between functional polymorphisms in the TNF-alpha gene and obsessive-compulsive disorder
Carolina Cappi et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2012)
Beta adrenergic blockade decreases the immunomodulatory effects of social disruption stress
M. L. Hanke et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
Glucocorticoids mediate stress-induced priming of microglial pro-inflammatory responses
Matthew G. Frank et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABAA receptors
Maria S. Garcia-Gutierrez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Evidence that Microglia Mediate the Neurobiological Effects of Chronic Psychological Stress on the Medial Prefrontal Cortex
M. Hinwood et al.
CEREBRAL CORTEX (2012)
Minocycline Therapeutic Potential in Psychiatry
Olivia M. Dean et al.
CNS DRUGS (2012)
Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?
Robert K. McNamara et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2012)
The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes
Wouter Beumer et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Serum response factor modulates neuron survival during peripheral axon injury
Sina Stern et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment
Imran B. Chaudhry et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
CHRONIC, NONINVASIVE GLUCOCORTICOID ADMINISTRATION SUPPRESSES LIMBIC ENDOCANNABINOID SIGNALING IN MICE
N. P. Bowles et al.
NEUROSCIENCE (2012)
Early Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury Is a Protective Response Involved in Spontaneous Recovery
Angel Arevalo-Martin et al.
PLOS ONE (2012)
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
Alline Cristina Campos et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
F. M. Leweke et al.
TRANSLATIONAL PSYCHIATRY (2012)
Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ
Huizhi Du et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Minocycline attenuates the development of diabetic neuropathic pain: Possible anti-inflammatory and anti-oxidant mechanisms
Kavita Pabreja et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?
Johann Steiner et al.
JOURNAL OF NEUROINFLAMMATION (2011)
β-Adrenergic Receptor Antagonism Prevents Anxiety-Like Behavior and Microglial Reactivity Induced by Repeated Social Defeat
Eric S. Wohleb et al.
JOURNAL OF NEUROSCIENCE (2011)
Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice
Maria S. Garcia-Gutierrez et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
Ana Maria Martin-Moreno et al.
MOLECULAR PHARMACOLOGY (2011)
Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells
Dexiang Liu et al.
NEUROPHARMACOLOGY (2011)
Regulatory Role of Cannabinoid Receptor 1 in Stress-Induced Excitotoxicity and Neuroinflammation
Silvia Zoppi et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice
Antonio Ortega-Alvaro et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Brain Cannabinoid CB2 Receptor in Schizophrenia
Hiroki Ishiguro et al.
BIOLOGICAL PSYCHIATRY (2010)
A Meta-Analysis of Cytokines in Major Depression
Yekta Dowlati et al.
BIOLOGICAL PSYCHIATRY (2010)
Cannabinoid Receptors and Endocannabinoids: Role in Neuroinflammatory and Neurodegenerative Disorders
Tiziana Bisogno et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2010)
Cannabidiol Induces Intracellular Calcium Elevation and Cytotoxicity in Oligodendrocytes
Susana Mato et al.
GLIA (2010)
A Double-Blind, Randomized Study of Minocycline for the Treatment of Negative and Cognitive Symptoms in Early-Phase Schizophrenia
Yechiel Levkovitz et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-α: relationship to CNS immune responses and depression
C. L. Raison et al.
MOLECULAR PSYCHIATRY (2010)
The myeloid cells of the central nervous system parenchyma
Richard M. Ransohoff et al.
NATURE (2010)
Endocannabinoids Potentiate Synaptic Transmission through Stimulation of Astrocytes
Marta Navarrete et al.
NEURON (2010)
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Florent Ginhoux et al.
SCIENCE (2010)
Evidence for an Interaction Between Familial Liability and Prenatal Exposure to Infection in the Causation of Schizophrenia
Mary C. Clarke et al.
AMERICAN JOURNAL OF PSYCHIATRY (2009)
Minocycline and neurodegenerative diseases
Hye-Sun Kim et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
CLINICAL TRIAL OF ADJUNCTIVE CELECOXIB TREATMENT IN PATIENTS WITH MAJOR DEPRESSION: A DOUBLE BLIND AND PLACEBO CONTROLLED TRIAL
Shahin Akhondzadeh et al.
DEPRESSION AND ANXIETY (2009)
Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain
Jian-You Guo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Social Interactions, Stress, and Immunity
Ronit Avitsur et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2009)
Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study
Janine Doorduin et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation
Edgar Alfonso Romero-Sandoval et al.
MOLECULAR PAIN (2009)
Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis
Yannick Marchalant et al.
NEUROBIOLOGY OF DISEASE (2009)
Endocannabinoid signaling in microglial cells
Nephi Stella
NEUROPHARMACOLOGY (2009)
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Angelo A. Izzo et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Microglia Activation in Recent-Onset Schizophrenia: A Quantitative (R)-[11C]PK11195 Positron Emission Tomography Study
Bart N. van Berckel et al.
BIOLOGICAL PSYCHIATRY (2008)
Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study
Fabiano G. Nery et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia
Christopher J. Henry et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Role of CB2 receptors in neuroprotective effects of cannabinoids
Javier Fernandez-Ruiz et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease
Istvan Katona et al.
NATURE MEDICINE (2008)
From inflammation to sickness and depression: when the immune system subjugates the brain
Robert Dantzer et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline
Yuko Fujita et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Obsessive-compulsive disorder and immunology: A review
Felipe Filardi da Rocha et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Antiaversive Effects of Cannabinoids: Is the Periaqueductal Gray Involved?
F. A. Moreira et al.
NEURAL PLASTICITY (2008)
In vivo modulation of LPS-induced alterations in brain and peripheral cytokines and HPA axis activity by cannabinoids
Michelle Roche et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones
J. Steiner et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury
Yaniv Ziv et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages:: role of IL-10 and ERK1/2 kinase signaling
F Correa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Cannabinoid receptors in microglia of the central nervous system: immune functional relevance
GA Cabral et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
IL-6 levels decrease with SSRI treatment in patients with major depression
AD Basterzi et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2005)
IDO and interferon-α-induced depressive symptoms:: a shift in hypothesis from tryptophan depletion to neurotoxicity
MC Wichers et al.
MOLECULAR PSYCHIATRY (2005)
Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy
KJ Valenzano et al.
NEUROPHARMACOLOGY (2005)
Prevention of Alzheimer's disease pathology by cannabinoids:: Neuroprotection mediated by blockade of microglial activation
BG Ramírez et al.
JOURNAL OF NEUROSCIENCE (2005)
Cytokines and major depression
OJG Schiepers et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
Jared Ehrhart et al.
JOURNAL OF NEUROINFLAMMATION (2005)
Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism
EJ Carrier et al.
MOLECULAR PHARMACOLOGY (2004)
Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia
T Mizuno et al.
NEUROPHARMACOLOGY (2004)
The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease
VH Perry
BRAIN BEHAVIOR AND IMMUNITY (2004)
Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system
M Tomás-Camardiel et al.
NEUROBIOLOGY OF DISEASE (2004)
Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms
A Giuffrida et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Inflammation is detrimental for neurogenesis in adult brain
CT Ekdahl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Liquid chromatographic determination of minocycline in brain-to-plasma distribution studies in the rat
M Colovic et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Anandamide inhibits nuclear factor-κB activation through a cannabinoid receptor-independent pathway
R Sancho et al.
MOLECULAR PHARMACOLOGY (2003)
Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder
C Tuglu et al.
PSYCHOPHARMACOLOGY (2003)
Differences in interleukins' patterns between dysthymia and major depression
J Schlatter et al.
EUROPEAN PSYCHIATRY (2001)
Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics
K Radewicz et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2000)
Share Paper
